[go: up one dir, main page]

AU3228789A - Biologically active proteins - Google Patents

Biologically active proteins

Info

Publication number
AU3228789A
AU3228789A AU32287/89A AU3228789A AU3228789A AU 3228789 A AU3228789 A AU 3228789A AU 32287/89 A AU32287/89 A AU 32287/89A AU 3228789 A AU3228789 A AU 3228789A AU 3228789 A AU3228789 A AU 3228789A
Authority
AU
Australia
Prior art keywords
biologically active
active proteins
proteins
biologically
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU32287/89A
Inventor
Jean-Michel Dayer
Philippe Lucien Seckinger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU3228789A publication Critical patent/AU3228789A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU32287/89A 1988-03-31 1989-03-30 Biologically active proteins Abandoned AU3228789A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8807803 1988-03-31
GB888807803A GB8807803D0 (en) 1988-03-31 1988-03-31 Biochemical product

Publications (1)

Publication Number Publication Date
AU3228789A true AU3228789A (en) 1989-10-05

Family

ID=10634493

Family Applications (1)

Application Number Title Priority Date Filing Date
AU32287/89A Abandoned AU3228789A (en) 1988-03-31 1989-03-30 Biologically active proteins

Country Status (12)

Country Link
JP (1) JPH02117700A (en)
KR (1) KR890014125A (en)
AU (1) AU3228789A (en)
BE (1) BE1001845A4 (en)
DE (1) DE3910323A1 (en)
DK (1) DK156589A (en)
FR (1) FR2629345A1 (en)
GB (2) GB8807803D0 (en)
IL (1) IL89804A0 (en)
IT (1) IT1232827B (en)
NL (1) NL8900779A (en)
SE (1) SE8901115L (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU630497B2 (en) * 1989-09-05 1992-10-29 Immunex Corporation Tumor necrosis factor-alpha and -beta receptors

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83878A (en) * 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
US5811261A (en) * 1988-09-12 1998-09-22 Yeda Research And Development Co. Ltd. Expression of the recombinant tumor necrosis factor binding protein I (TBP-I)
US6221675B1 (en) 1989-04-21 2001-04-24 Amgen, Inc. TNF receptors, TNF binding proteins and DNAs coding for them
US7264944B1 (en) 1989-04-21 2007-09-04 Amgen Inc. TNF receptors, TNF binding proteins and DNAs coding for them
ATE289350T1 (en) 1989-04-21 2005-03-15 Amgen Inc TNF RECEPTOR, TNF BINDING PROTEINS AND DNA CODING THEREOF
IL95031A (en) * 1989-07-18 2007-03-08 Amgen Inc Method for the production of a human recombinant tumor necrosis factor inhibitor
US6143866A (en) * 1989-07-18 2000-11-07 Amgen, Inc. Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
US5945397A (en) * 1989-09-05 1999-08-31 Immunex Corporation Purified p75 (type II) tumor necrosis factor receptor polypeptides
US5605690A (en) * 1989-09-05 1997-02-25 Immunex Corporation Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
ATE236249T1 (en) * 1989-09-12 2003-04-15 Hoffmann La Roche TFN-BINDING PROTEINS
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
WO1992001002A1 (en) * 1990-07-11 1992-01-23 Teijin Limited Tumor necrosis factor activity inhibitor and production thereof
EP0480389A1 (en) * 1990-10-12 1992-04-15 Hoechst Aktiengesellschaft Inhibitors for forming tumor necrosis factor, process for their production and their use
GEP20002142B (en) * 1991-01-18 2000-06-25 Amgen Inc Method for Treatment and Prevention of TNF Mediated Diseases
JPH06510122A (en) * 1991-08-23 1994-11-10 エヌチップ　インコーポレイテッド Burn-in techniques for unpackaged integrated circuits
IT1276040B1 (en) * 1993-07-27 1997-10-24 Angelini Francesco Ist Ricerca USE OF BENZIDAMINE IN THE TREATMENT OF PATHOLOGICAL STATES CAUSED BY TNF
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
EP0949931B1 (en) 1996-12-06 2008-08-27 Amgen Inc., Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
PT942740E (en) 1996-12-06 2004-01-30 Amgen Inc COMBINATION THERAPY USING A TNF LIGACTION PROTEIN FOR TREATMENT OF TNF-MEDIATED DISEASES
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
PH12012502439A1 (en) 2001-06-26 2013-06-17 Amgen Inc Antibodies to opgl
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
JP2006517191A (en) 2002-12-30 2006-07-20 アムジエン・インコーポレーテツド Combination therapy using costimulatory factors
US7833527B2 (en) 2006-10-02 2010-11-16 Amgen Inc. Methods of treating psoriasis using IL-17 Receptor A antibodies
TW201117824A (en) 2009-10-12 2011-06-01 Amgen Inc Use of IL-17 receptor a antigen binding proteins
JP5743234B2 (en) 2010-01-15 2015-07-01 キリン−アムジェン・インコーポレーテッド Antibody formulations and treatment regimens
US20140234330A1 (en) 2011-07-22 2014-08-21 Amgen Inc. Il-17 receptor a is required for il-17c biology
ES2760002T3 (en) 2014-03-31 2020-05-12 Amgen K A Inc Methods of treating nail and scalp psoriasis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU630497B2 (en) * 1989-09-05 1992-10-29 Immunex Corporation Tumor necrosis factor-alpha and -beta receptors

Also Published As

Publication number Publication date
NL8900779A (en) 1989-10-16
IL89804A0 (en) 1989-09-28
IT1232827B (en) 1992-03-05
SE8901115D0 (en) 1989-03-30
JPH02117700A (en) 1990-05-02
IT8947794A0 (en) 1989-03-30
KR890014125A (en) 1989-10-21
BE1001845A4 (en) 1990-03-20
DK156589A (en) 1989-10-01
GB8807803D0 (en) 1988-05-05
GB2218101A (en) 1989-11-08
FR2629345A1 (en) 1989-10-06
DE3910323A1 (en) 1989-10-19
DK156589D0 (en) 1989-03-30
SE8901115L (en) 1989-10-01
GB8907148D0 (en) 1989-05-10

Similar Documents

Publication Publication Date Title
AU3228789A (en) Biologically active proteins
AU3162889A (en) Breach-cooled structure
AU3418389A (en) Nerve growth factor peptides
AU3362889A (en) Peptide derivatives
AU626147B2 (en) Fibrinolytic proteins
AU5102990A (en) Fungicidally active preparations
AU3588189A (en) Polypeptide compounds
AU3414689A (en) Therapeutic peptides
AU1413488A (en) Pharmacologically active peptides
AU3977589A (en) Novel peptides
IL75828A (en) Immobilization by biologically active proteins
AU4385689A (en) Electrode
AU610900B2 (en) Immunosuppressant peptides
AU3804589A (en) Novel proteins
AU3783489A (en) Fishing aid
AU578644B2 (en) Biologically active amide derivatives
AU587083B2 (en) Biologically active amide derivatives
AU557783B2 (en) Biologically active peptides
AU6272490A (en) Biologically active compositions
AU3804689A (en) Modified proteins
AU8589382A (en) Biologically active peptides
AU3843289A (en) Blood substitute
GB8816095D0 (en) Protein
AU3295989A (en) Gestation-recognizing protein
EP0253245A3 (en) Biologically active peptides tan-866